BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17273862)

  • 1. Mesna or cysteine prevents chloroacetaldehyde-induced cell death of human proximal tubule cells.
    Schwerdt G; Kirchhoff A; Freudinger R; Wollny B; Benesic A; Gekle M
    Pediatr Nephrol; 2007 Jun; 22(6):798-803. PubMed ID: 17273862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells.
    Schwerdt G; Gordjani N; Benesic A; Freudinger R; Wollny B; Kirchhoff A; Gekle M
    Pediatr Nephrol; 2006 Jan; 21(1):60-7. PubMed ID: 16267686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloroacetaldehyde as a sulfhydryl reagent: the role of critical thiol groups in ifosfamide nephropathy.
    Benesic A; Schwerdt G; Freudinger R; Mildenberger S; Groezinger F; Wollny B; Kirchhoff A; Gekle M
    Kidney Blood Press Res; 2006; 29(5):280-93. PubMed ID: 17035713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro.
    Yaseen Z; Michoudet C; Baverel G; Dubourg L
    Pediatr Nephrol; 2008 Apr; 23(4):611-8. PubMed ID: 18204866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide toxicity in cultured proximal renal tubule cells.
    Springate J; Taub M
    Pediatr Nephrol; 2007 Mar; 22(3):358-65. PubMed ID: 17072651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.
    Springate J; Chan K; Lu H; Davies S; Taub M
    In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):314-7. PubMed ID: 10476917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.
    Patzer L; Hernando N; Ziegler U; Beck-Schimmer B; Biber J; Murer H
    Kidney Int; 2006 Nov; 70(10):1725-34. PubMed ID: 17003823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.
    Zaki EL; Springate JE; Taub M
    Toxicol In Vitro; 2003 Aug; 17(4):397-402. PubMed ID: 12849722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ifosfamide and mesna: effects on the Na/H exchanger activity in renal epithelial cells in culture (LLC-PK1).
    Mohrmann M; Küpper N; Schönfield B; Brandis M
    Ren Physiol Biochem; 1995; 18(3):118-27. PubMed ID: 7542792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbed Ca2+-signaling by chloroacetaldehyde: a possible cause for chronic ifosfamide nephrotoxicity.
    Benesic A; Schwerdt G; Mildenberger S; Freudinger R; Gordjani N; Gekle M
    Kidney Int; 2005 Nov; 68(5):2029-41. PubMed ID: 16221203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide.
    Brüggemann SK; Kisro J; Wagner T
    Cancer Res; 1997 Jul; 57(13):2676-80. PubMed ID: 9205076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione.
    Pendyala L; Creaven PJ; Schwartz G; Meropol NJ; Bolanowska-Higdon W; Zdanowicz J; Murphy M; Perez R
    Clin Cancer Res; 2000 Apr; 6(4):1314-21. PubMed ID: 10778956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nephrotoxic Ifosfamide-metabolite chloroacetaldehyde interferes with renal extracellular matrix homeostasis.
    Benesic A; Schwerdt G; Hennemeier I; Sauvant C; Mildenberger S; Gekle M
    Cell Physiol Biochem; 2014; 33(4):1106-16. PubMed ID: 24732969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule.
    Yaseen Z; Michoudet C; Baverel G; Dubourg L
    Arch Toxicol; 2008 Sep; 82(9):607-14. PubMed ID: 18214444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of ifosfamide and chloroacetaldehyde renal toxicity through integration of in vitro liver-kidney microfluidic data and pharmacokinetic-system biology models.
    Leclerc E; Hamon J; Bois FY
    J Appl Toxicol; 2016 Feb; 36(2):330-9. PubMed ID: 26152902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.
    Springate JE
    J Appl Toxicol; 1997; 17(1):75-9. PubMed ID: 9048231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide induced depletion of glutathione in human peripheral blood lymphocytes and protection by mesna.
    Meier T; Allenbacher A; Mueller E; Multhoff G; Botzler C; Wiesnet M; Issels R
    Anticancer Drugs; 1994 Aug; 5(4):403-9. PubMed ID: 7949243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrolein and chloroacetaldehyde: an examination of the cell and cell-free biomarkers of toxicity.
    MacAllister SL; Martin-Brisac N; Lau V; Yang K; O'Brien PJ
    Chem Biol Interact; 2013 Feb; 202(1-3):259-66. PubMed ID: 23220588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/short communication.
    Pohl J; Stekar J; Hilgard P
    Arzneimittelforschung; 1989 Jun; 39(6):704-5. PubMed ID: 2505783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo.
    Börner K; Kisro J; Brüggemann SK; Hagenah W; Peters SO; Wagner T
    Drug Metab Dispos; 2000 May; 28(5):573-6. PubMed ID: 10772637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.